EUVIMEDEUVIMED entdecken
Open Access

Nursing Considerations for CAR T-Cell Therapy: Management of Cytokine Release Syndrome and Immune Effector Cell–Associated Neurotoxicity Syndrome

Demi M Miller

Clinical Journal of Oncology Nursing · 15.07.2026

DOI: 10.1188/26.cjon.s2.e67-e72 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Journal of Oncology Nursing, online erschienen am 15.07.2026. Verfasst von Demi M Miller. Beteiligte Einrichtung: Demi M. Miller. Hauptthemen laut MEDLINE: Neurotoxicity Syndromes, Cytokine Release Syndrome, Immunotherapy, Adoptive, Oncology Nursing. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Chimeric antigen receptor (CAR) T-cell therapy is a promising treatment for certain hematologic malignancies, but many nurses are not trained in caring for two common side effects, cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS). OBJECTIVES: This article provides foundational knowledge of CRS and ICANS, including the oncology nurse's role in toxicity monitoring, care coordination, and patient education. METHODS: To support safe, evidence-based CAR T-cell therapy administration, this article discusses grading guidelines, nursing assessments, interventions, and education strategies for CRS and ICANS. FINDINGS: Nurses serve a key role in mitigating CRS and ICANS through early recognition, continuous monitoring, therapeutic intervention, and patient and caregiver education. Using standardized protocols, frequently monitoring vital signs, and performing neurologic assessments optimize patient safety and outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurotoxicity SyndromesCytokine Release SyndromeImmunotherapy, AdoptiveOncology NursingHematologic NeoplasmsHumansFemaleMaleReceptors, Chimeric AntigenAdult

Stichwörter der Autor:innen

CAR T-cell therapyICANScytokine release syndromeneurotoxicity

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Demi M. Miller.

Zitieren

APA

Miller, D. M. (2026). Nursing Considerations for CAR T-Cell Therapy: Management of Cytokine Release Syndrome and Immune Effector Cell–Associated Neurotoxicity Syndrome. Clinical Journal of Oncology Nursing. https://doi.org/10.1188/26.cjon.s2.e67-e72

Vancouver

Miller DM. Nursing Considerations for CAR T-Cell Therapy: Management of Cytokine Release Syndrome and Immune Effector Cell–Associated Neurotoxicity Syndrome. Clinical Journal of Oncology Nursing. 2026. doi:10.1188/26.cjon.s2.e67-e72

BibTeX
@article{Miller2026,
  author = {Miller, Demi M},
  title = {Nursing Considerations for CAR T-Cell Therapy: Management of Cytokine Release Syndrome and Immune Effector Cell–Associated Neurotoxicity Syndrome},
  journal = {Clinical Journal of Oncology Nursing},
  year = {2026},
  doi = {10.1188/26.cjon.s2.e67-e72}
}
Kostenlos starten →